Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Tianyin Pharma Says $25 Million Production Facility Nearly Complete

publication date: Oct 10, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Tianyin Pharmaceuticals reported that its new production facility, which will cost $25 million, is on track to be completed early next year. Tianyin was forced to move two of its plants by the Chengdu municipal government, which designates particular areas for specific industries. Tianyin will combine its pre-extraction and formulation operations into a single facility with 30% greater capacity. However, the large capital expenditure comes at a bad time for Tianyin. More details...

Stock Symbol: (AMEX: TPI)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...